Photobiomodulation Explained: How Red Light Therapy Works

What Is Photobiomodulation?

Photobiomodulation (PBM) is the use of specific wavelengths of red and near infrared light to trigger biological responses in living cells. The process is photochemical rather than thermal: it does not rely on heat and does not require a chemical agent.

PBM works when photons are absorbed by light-sensitive molecules inside cells, known as chromophores. The absorbed energy alters cellular activity and initiates a cascade of downstream biological responses.

The therapeutic window for photobiomodulation spans approximately 600nm to 1100nm, covering both visible red and near infrared (NIR) light. Within this range, different wavelengths penetrate to different tissue depths and interact with different molecular targets.

This wavelength range is not arbitrary. Below 600nm, absorption by surface chromophores is so high that most photons are absorbed before reaching clinically relevant tissue depths. Above 1100nm, water absorption increases sharply, limiting light penetration and reducing the amount of energy that reaches target cells.

Why Scientists Use the Term Photobiomodulation

The term photobiomodulation (PBM) replaced the earlier phrase low-level laser therapy (LLLT) because it describes the biological mechanism rather than the device used to deliver the light. Modern PBM can be delivered by both lasers and LEDs, making the newer terminology more accurate and device-agnostic.

The term also distinguishes PBM from other light-based therapies that work through different mechanisms:

• UV therapy suppresses immune activity through controlled DNA damage.
• Photodynamic therapy uses light-activated drugs to destroy targeted tissue.
• Infrared heat therapy relies on thermal effects and tissue heating.
• Photobiomodulation works through photon absorption and cellular signalling, without requiring heat or chemical agents.

For this reason, researchers typically use photobiomodulation when discussing the underlying science, while red light therapy remains the more common consumer term.

How PBM Differs from Heat Therapy

Heat therapy works by raising tissue temperature. The resulting physiological effects, including vasodilation, increased enzyme activity, and reduced muscle stiffness, are temperature-dependent.

Photobiomodulation (PBM) works differently. At therapeutic doses, PBM produces little to no meaningful tissue heating. Instead, red and near infrared photons are absorbed by cellular chromophores, triggering biochemical and cellular signalling pathways.

Both approaches may support outcomes such as recovery and pain management, but they achieve those effects through different mechanisms. Because PBM is non-thermal, it can also be used in situations where applying heat may be inappropriate, such as certain inflammatory or acute injury states.

How Light Interacts With Human Cells

Chromophores and Light Absorption (Physics Layer)

A chromophore is a molecule that absorbs light at specific wavelengths. When a chromophore absorbs a photon, the energy is either converted into heat, re-emitted, or used to drive a biological or chemical reaction.

The main endogenous chromophores in human tissue include:

• Melanin – strongly absorbs visible light and reduces penetration at shorter wavelengths
• Oxyhaemoglobin and deoxyhaemoglobin – absorb selectively in parts of the visible spectrum, limiting penetration of certain wavelengths
• Water – becomes the dominant absorber above ~1000nm
• Cytochrome c oxidase (CCO) – mitochondrial enzyme that serves as a primary photobiomodulation target

The therapeutic window for photobiomodulation (approximately 600–1000nm) exists because absorption by melanin, haemoglobin, and water is relatively low within this range. This allows red and near infrared photons to reach deeper tissue structures.

Cytochrome c Oxidase (CCO) and Mitochondrial Light Interaction (Mechanism Layer) 

Cytochrome c oxidase (CCO) is the terminal enzyme in the mitochondrial electron transport chain. It facilitates the transfer of electrons to oxygen, a key step in establishing the proton gradient required for ATP synthesis.

CCO contains haem and copper centres that exhibit absorption sensitivity in the red and near infrared spectrum, with key interaction ranges around 660nm, 810nm, and 830nm.

In metabolically stressed or inflamed tissue, nitric oxide (NO) can bind reversibly to CCO and reduce oxygen availability at the active site. This temporarily slows electron transport and decreases mitochondrial ATP production.

When photons are absorbed by CCO at relevant wavelengths, this interaction can promote dissociation of nitric oxide from the enzyme complex. This restores oxygen access and improves electron transport efficiency, increasing mitochondrial respiration and ATP synthesis.

This mechanism is context-dependent: effects are typically more pronounced in tissue where CCO activity is already partially inhibited, such as injured or inflamed regions.

Downstream Cellular Signaling (Secondary Effects Layer) 

Following CCO activation, increased mitochondrial activity can trigger secondary intracellular signalling processes.

These include:

• Reactive oxygen species (ROS): transient, low-level signalling molecules involved in gene regulation related to repair and inflammation modulation
• Nitric oxide (NO) release: NO displaced from CCO enters local circulation and may contribute to vasodilation and microvascular regulation
• Calcium flux: changes in intracellular calcium signalling that can influence mitochondrial and cellular activity

These pathways are downstream effects of mitochondrial activation rather than primary photonic targets. Their expression varies depending on tissue type and physiological state.

ATP and Mitochondria Explained

What ATP Does (Energy Currency Layer) 

ATP (adenosine triphosphate) is the primary energy transfer molecule used by cells.

It does not function as an energy storage system. Instead, it transfers usable energy to drive cellular processes such as:

• muscle contraction
• protein synthesis
• ion transport
• cell signalling
• cell division

ATP is produced and consumed locally within cells, meaning each tissue must generate its own supply based on demand.

Energy deficits therefore occur at the site of impaired cellular function rather than through systemic distribution failure.

Why Mitochondria Matter (Production System Layer) 

Mitochondria are the primary site of ATP production in human cells.

Approximately 90% of ATP is generated through oxidative phosphorylation within mitochondria. The remaining fraction is produced via glycolysis, which is faster but significantly less efficient.

When mitochondrial function is optimal, cells maintain high ATP availability to support repair, immune activity, and structural maintenance.

When mitochondrial function is impaired, cells rely more heavily on glycolysis, which leads to:

• reduced energy efficiency
• increased lactate production
• higher oxidative stress signalling
• slower repair processes

Mitochondrial function is therefore a key determinant of cellular energy capacity, but it is dynamically responsive rather than fixed.

Photobiomodulation and Energy Production (Reference Layer) 

Photobiomodulation influences cellular energy availability by acting on mitochondrial processes described in the Cytochrome c Oxidase (CCO) mechanism section.

Its primary effect is not direct ATP delivery, but modulation of mitochondrial efficiency in cells where energy production is constrained.

This effect is context-dependent and is most pronounced in tissue where mitochondrial activity is already reduced due to stress, injury, or inflammation.

Red Light vs Near Infrared Light

Visible Red Light

Visible red light ranges from 620nm to 700nm. It is absorbed more by melanin and haemoglobin than near infrared light, which limits its penetration depth.

Penetration typically reaches 1–2 millimetres into tissue, meaning its primary effects occur in the epidermis and upper dermis.

At this depth, the main cellular targets include:

• Keratinocytes
• Fibroblasts
• Langerhans cells

The most well-documented effects of visible red light include increased fibroblast activity, collagen synthesis, and modulation of surface-level inflammation. As a result, research in this wavelength range is primarily focused on skin health, wound healing, and superficial tissue repair.

Near Infrared Light

Near infrared (NIR) light ranges from 700nm to 1100nm and is invisible to the human eye.

In this range, melanin and haemoglobin absorb significantly less light compared to visible wavelengths, allowing photons to penetrate deeper into tissue before scattering or absorption.

Penetration typically reaches 3–5 centimetres at wavelengths such as 850nm, depending on tissue composition and device irradiance.

At these depths, the primary biological targets shift to:

• Skeletal muscle
• Tendons
• Joint capsules
• Neural tissue (upper range of NIR)

Near infrared wavelengths also overlap with absorption peaks of cytochrome c oxidase (CCO), particularly around 810nm. This makes NIR the primary wavelength range for musculoskeletal recovery and deeper tissue applications.

Surface vs Deep Tissue Effects

Wavelength selection should match the anatomical depth of the target tissue.

Visible red light (e.g., 660nm) is primarily absorbed in superficial layers. As a result, it does not deliver sufficient irradiance to deep structures such as joints or muscle.

Near infrared light (e.g., 850nm) penetrates deeper and is better suited for musculoskeletal and subdermal targets. However, when applied to superficial wounds, much of its energy passes below the intended surface layer.

Most commercial devices combine red and near infrared wavelengths to target both superficial and deep tissues within a single session. However, the clinical outcome depends on the ratio and selection of wavelengths, as this determines which tissue depths receive the highest effective dose.

For a detailed comparison of the two most widely used wavelengths in commercial devices, see the red and near infrared light comparison for 630nm vs 850nm.

Red Light Therapy Wavelengths Explained

630nm (Lower Red Boundary) 

630nm sits at the lower boundary of the photobiomodulation range.

It is primarily absorbed in superficial tissue layers due to higher melanin interaction compared to longer wavelengths.

Primary classification:

• Visible red light
• Superficial penetration range

Primary application:

• epidermal-level skin support
• surface barrier processes

660nm (Primary Red Therapeutic Peak) 

660nm is one of the most widely studied red light wavelengths in photobiomodulation.

It is strongly associated with superficial tissue applications due to its interaction profile within the dermal layer.

Primary classification:

• Visible red light
• high-research therapeutic red wavelength

Primary application:

• skin repair processes
• collagen-related surface tissue support

It is frequently used as the active wavelength in clinical trials due to its well-characterised CCO interaction and consistent penetration profile across study settings.

810nm (Deep Tissue / Neural Range) 

810nm lies within the near infrared range and is commonly used in research involving deeper tissue targets.

It is frequently selected in transcranial applications due to its penetration profile and biological activity window.

Primary classification:

• near infrared light
• deep tissue + neural range

Primary application:

• transcranial research
• deep muscle and neural tissue targeting

810nm is the most commonly used wavelength in studies targeting neural tissue directly.

850nm (Musculoskeletal Range) 

850nm is the most widely used commercial near infrared wavelength.

It is commonly associated with musculoskeletal applications due to its penetration depth and tissue reach characteristics.

Primary classification:

• near infrared light
• musculoskeletal penetration range

Primary application:

• muscle recovery
• joint and soft tissue support

850nm is commonly paired with 660nm in commercial devices to provide combined superficial and deep tissue coverage within a single treatment session.

904nm (Superpulsed Deep Penetration Mode) 

904nm is typically delivered in superpulsed mode rather than continuous emission.

This delivery method produces high peak power pulses with low average energy output, which alters tissue penetration dynamics.

Primary classification:

• near infrared light
• superpulsed delivery system

Primary application:

• deep joint targeting
• nerve-adjacent applications

For a direct evidence comparison with 1064nm, the 904nm vs 1064nm guide covers both wavelengths in detail.

1064nm (Deepest Clinical Range) 

1064nm operates at the far end of the photobiomodulation spectrum and is typically delivered via high-power laser systems.

It is used in applications requiring maximal depth penetration.

Primary classification:

• near infrared (far-range)
• high-intensity laser system range

Primary application:

• deep joint structures
• deep tissue and axial applications

Its effectiveness is partly dependent on high irradiance output, which helps overcome attenuation from water absorption at this wavelength range.

Wavelength Comparison Table

Wavelength	Type	Primary Target	Approx. Penetration Depth	Key Research Area
630nm	Visible Red	Epidermis	~1mm	Skin repair, wound healing
660nm	Visible Red	Dermis, surface tissue	~2mm	Collagen, inflammation, hair follicles
810nm	Near Infrared	Muscle, neural tissue	~3cm	Brain, deep muscle, neural recovery
850nm	Near Infrared	Muscle, joints	~3–5cm	Recovery, pain, deep tissue
904nm	Near Infrared	Joints, neural	~5cm+	Deep joint, neural, pulsed therapy
1064nm	Near Infrared	Deep joint, neural	Variable	Deep pathology, Class IV applications

What Does Frequency (Hz) Mean?

In photobiomodulation, frequency (Hz) refers to how many times per second a light source cycles between being on and off during pulsed emission. 

Continuous vs Pulsed Light

Continuous wave (CW) emission delivers light at a constant output throughout the treatment session. Irradiance remains stable, and total energy delivery increases linearly over time.

Pulsed emission alternates between on and off states at a defined frequency measured in hertz (Hz). For example, 10 Hz corresponds to 10 complete on–off cycles per second.

During the off phase, no light is delivered to tissue. This changes both the temporal structure of energy delivery and the total dose compared to continuous wave systems under equivalent conditions.

At sub-thermal irradiance levels used in photobiomodulation, neither mode produces clinically significant heating. The relevance of pulsing is therefore not thermal, but related to delivery pattern and biological response.

Why Frequency Matters

Neural activity occurs in rhythmic oscillatory bands associated with different physiological states:

• Delta (1–4 Hz): deep sleep
• Theta (4–8 Hz): memory encoding
• Alpha (8–12 Hz): relaxed wakefulness
• Beta (12–30 Hz): active cognition
• Gamma (30–100 Hz): attention and high-level processing

These oscillations reflect coordinated neuronal firing patterns rather than simple descriptive categories.

The hypothesis in frequency-specific photobiomodulation is that pulsed light may interact with these rhythms. Potential mechanisms include entrainment, modulation of neuronal excitability, or amplification of oscillatory networks. This remains a research hypothesis rather than an established mechanism.

Therapeutic Frequency Ranges

Outside neural applications, frequency effects are less well characterised but appear in several research domains.

10 Hz
Used in pain modulation protocols and associated with low-frequency neuromodulatory effects. Its rationale is partly informed by transcutaneous electrical nerve stimulation (TENS), which shows frequency-dependent analgesic responses.

40 Hz
The most studied frequency in transcranial photobiomodulation research. The 40 Hz gamma band is associated with attention and cognition and is disrupted in Alzheimer’s disease. Preclinical studies show that 40 Hz sensory stimulation can induce gamma entrainment and reduce amyloid burden in animal models. Early human PBM studies are investigating similar effects.

100 Hz and above
Appears in musculoskeletal and peripheral nerve applications. These higher frequencies are generally used for tissue-level modulation rather than neural oscillatory entrainment.

Tissue Penetration and Biological Effects

Skin

Skin is the most accessible target in photobiomodulation and has the largest clinical evidence base.

Red wavelengths (630nm and 660nm) primarily affect the epidermis and dermis, where they are absorbed by fibroblasts and keratinocytes. This interaction activates cytochrome c oxidase (CCO) and increases local ATP production.

Documented biological effects include:

• Increased fibroblast proliferation
• Upregulated collagen type I and III synthesis
• Reduced inflammatory cytokine expression
• Accelerated keratinocyte migration

The biphasic dose response is particularly relevant in skin applications. Above the optimal irradiance range, the same biological processes that are stimulated at lower doses may become inhibited. As a result, dose control is more critical in superficial tissue due to high photon deposition within a limited volume.

Muscles

Near infrared (NIR) wavelengths penetrate into skeletal muscle, where mitochondria-dense fibres are the primary target.

Muscle applications are typically studied in two contexts:

Pre-exercise use
Photobiomodulation may delay fatigue onset and reduce markers of exercise-induced muscle damage. The proposed mechanism is improved baseline mitochondrial efficiency, reducing reliance on anaerobic metabolism under load.

Post-exercise use
Post-exercise application targets the inflammatory and oxidative stress response following mechanical strain. Studies report reductions in markers such as creatine kinase (CK) and interleukin-6 (IL-6).

These effects are consistent with improved mitochondrial function and modulation of downstream inflammatory signalling.

Joints

Joint structures require photons to pass through multiple tissue layers, including skin, fat, and periarticular connective tissue.

Effective joint-level photobiomodulation typically requires near infrared wavelengths (850nm and above). Visible red wavelengths (660nm and below) do not reliably deliver sufficient irradiance to intra-articular structures.

Joint research focuses on:

• Synovial inflammation
• Cartilage metabolism
• Tendon and periarticular tissue repair

904nm superpulsed systems are particularly relevant for joint applications due to high peak power output, which may improve photon delivery through deeper tissue layers.

Brain Applications

The skull significantly attenuates light, making transcranial photobiomodulation dependent on wavelength, irradiance, and anatomical location.

Computational and experimental studies indicate that 810nm and 1064nm wavelengths can deliver measurable irradiance to cortical tissue, particularly in regions such as the prefrontal cortex where bone thickness is reduced.

At the cellular level, the primary target remains cytochrome c oxidase (CCO) in neurons and glial cells, resulting in increased ATP production.

Secondary effects include:

• Increased cerebral blood flow via nitric oxide (NO) release
• Potential modulation of neural oscillatory activity in frequency-pulsed protocols

These mechanisms are the basis for ongoing research in cognitive function, neuroprotection, and brain recovery applications.

What Research Currently Supports

Recovery

The strongest and most replicated evidence in photobiomodulation relates to post-exercise recovery.

Systematic reviews and meta-analyses report consistent reductions in:

• Delayed onset muscle soreness (DOMS)
• Creatine kinase (CK) levels
• Inflammatory markers following exercise

These effects are most consistent when near infrared (NIR) light is applied immediately before or after exercise, suggesting timing influences outcomes. This aligns with the mechanistic model in which early intervention modulates the inflammatory cascade during its initial phases..

Pain Relief

Photobiomodulation has been studied across musculoskeletal, neuropathic, and inflammatory pain conditions.

Proposed mechanisms include:

• Reduced prostaglandin synthesis
• Modulation of substance P activity
• Increased endorphin release

Overall findings across studies are directionally positive, but heterogeneity is high due to variation in:

• Wavelength
• Irradiance
• Frequency
• Treatment location
• Pain condition type

As a result, pooled effect sizes are difficult to interpret, and protocol-level conclusions require condition-specific analysis..

Skin Health

Skin repair and wound healing represent the longest-established clinical research area in photobiomodulation.

Red wavelengths, particularly 660nm, have demonstrated effects on:

• Fibroblast activation
• Keratinocyte proliferation
• Collagen synthesis

Clinical applications include wound healing, scar reduction, and photorejuvenation. While multiple randomized controlled trials report positive outcomes, study quality varies and long-term follow-up data remains limited.

Circulation

Photobiomodulation influences microcirculation primarily through nitric oxide (NO) signalling following cytochrome c oxidase (CCO) activation.

Observed effects include:

• Increased local blood flow
• Improved microvascular perfusion
• Reduced markers of ischemia in experimental models

This circulatory response is considered a downstream effect of mitochondrial activation rather than an independent photobiological pathway, meaning it occurs wherever CCO activation is present.

Cognitive Research

Transcranial photobiomodulation research has expanded significantly over the past decade.

Small randomized controlled trials using 810nm and 1064nm applied to prefrontal cortical regions have reported improvements in:

• Working memory
• Sustained attention
• Processing speed

However, most studies remain limited by small sample sizes and heterogeneous protocols. Larger, standardized trials are still in development.

The proposed mechanism combines:

• Increased mitochondrial ATP production in cortical neurons
• Enhanced cerebral blood flow via nitric oxide release

The cognitive research thread is covered in detail in the transcranial photobiomodulation guide.

Frequently Asked Questions

What is photobiomodulation? 

Photobiomodulation is the use of red and near infrared light to trigger biological responses in cells. It primarily works through activation of cytochrome c oxidase in mitochondria and is a photochemical rather than thermal process. 

How does red light therapy affect mitochondria? 

Red and near infrared light are absorbed by cytochrome c oxidase, which can improve mitochondrial electron transport and increase ATP production, especially in metabolically stressed tissue. 

What is ATP and why does it matter in red light therapy? 

ATP is the primary energy molecule in cells. Photobiomodulation supports ATP production by improving mitochondrial function, which is essential for cellular repair and recovery. 

What wavelength penetrates deepest? 

The deepest penetration is achieved by 904nm (superpulsed systems) and 1064nm (Class IV lasers). Among LED devices, 850nm typically reaches the deepest tissue levels (around 3–5 cm). 

What is the difference between red light and near infrared light? 

Red light (620–700nm) acts mainly on superficial skin layers, while near infrared light (700–1100nm) penetrates deeper into muscle, joints, and neural tissue. .

What does Hz mean in red light therapy? 

Hz refers to how many times per second light pulses on and off in pulsed mode. It is mainly relevant in neural and pain applications where frequency may influence biological responses.